Astrazeneca Pharma India Ltd. (ASTRAZEN) Share Price Hits Fresh 52-Week Low
- August 21, 2026
- Posted by: Harsh Piplani
- Category: News
Astrazeneca Pharma India Ltd. Share Price was at Rs 7,498.90 on 21 August 2026 at 9:53 AM IST, down Rs 5.40 or 0.07% from the previous close of Rs 7,504.30, after the stock touched a fresh 52-week low of Rs 7,480. With a market capitalisation of Rs 18,760.75 crore, the move has put the counter in focus for investors tracking Astrazeneca Pharma India Ltd. Share Price Today and broader Healthcare names.
The verified data confirms the price event clearly: the stock opened at Rs 7,580.50, also its intraday high so far, before slipping to the day low and new one-year low of Rs 7,480. Turnover stood at Rs 0.04 crore and current volume was 53 shares at the time of the update. That combination points to a fresh yearly low in price, but the supplied data does not establish a company-specific catalyst behind the decline.
For readers following Astrazeneca Pharma India Ltd. Stock News, the key issues now are straightforward. First, what exactly does today’s price action show? Second, how do the company’s valuation and profitability metrics compare with the Healthcare benchmark and selected peers? Third, does the stock’s current profile justify continued monitoring on Univest as part of Stocks in News and 52 Week Low Stocks screens? This Univest note addresses those questions using only verified data.
Astrazeneca Pharma India Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 7,498.9 |
| Previous Close | Rs 7,504.3 |
| Today's Change | Rs -5.4 (-0.07%) |
| Day Open | Rs 7,580.5 |
| Fresh 52-Week Low | Rs 7,480 |
| Day High | Rs 7,580.5 |
| Current Volume | 53 |
| Turnover | Rs 0.04 crore |
| Market Capitalisation | Rs 18,760.75 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 7,498.9. versus the previous close of Rs 7,504.3, a fall of 0.07%. The stock opened at Rs 7,580.5, reached Rs 7,580.5, touched Rs 7,480. Reported volume was 53.
Astrazeneca Pharma India Ltd. Share Price Today shows a mild percentage decline but a notable technical event: a fresh 52-week trough. The stock opened at Rs 7,580.50, reached the same intraday high of Rs 7,580.50, and then fell to Rs 7,480, which now stands as both the day low and the fresh 52 Week Low.
In absolute terms, Astrazeneca Pharma India Ltd. Share Price is lower by Rs 5.40 from the previous close of Rs 7,504.30. The day change of -0.07% looks small on the surface, but the fact that the stock recorded a new one-year low matters more than the percentage move alone. It signals that the counter has slipped below all other traded levels seen over the last 52 weeks.
The day’s trading range has also been relatively well defined so far. From the open and high of Rs 7,580.50 to the low of Rs 7,480, the stock has seen intraday pressure of Rs 100.50. The current price of Rs 7,498.90 places it only Rs 18.90 above the fresh yearly low, showing that Astrazeneca Pharma India Ltd. Share Price remains close to the weakest level of the session.
Volume participation has been limited in absolute terms, with 53 shares traded and turnover of Rs 0.04 crore. That makes this Astrazeneca Pharma India Ltd. Share Price Update important as a price milestone rather than a broad high-volume washout. In Share Market Today and Stock Market Today screens, such moves often attract attention because they reflect weak price action even without a large percentage drawdown. The next step is to see whether the company’s fundamentals offer context for this 52-week low move.
Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 18,760.75 crore |
| P/E Ratio | 50.55x |
| P/B Ratio | 1.94x |
| ROE | -0.78% |
| ROCE | 8.31% |
Astrazeneca Pharma India Ltd. was valued at a P/E ratio of 50.55x, a P/B ratio of 1.94x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 50.55x |
| Benchmark Median P/E | 21.42x |
| Benchmark Average P/E | 48.98x |
| Benchmark P/E Range | 0x to 1,614.49x |
| Company P/B Ratio | 1.94x |
| Benchmark Median P/B | 1.94x |
| Company ROE | -0.78% |
| Benchmark Median ROE | 11.09% |
| Company ROCE | 8.31% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 18,760.75 crore |
| Benchmark Median Market Cap | Rs 132.66 crore |
Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 50.55x, which is above the benchmark median of 21.42x, a difference of +135.99%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,803.21 | 50.55 | 1.94 | -0.78 | 8.31 |
| Dishman Carbogen Amcis Ltd. | DCAL | 2,700.59 | 166.73 | 0.41 | -2.89 | -0.26 |
| Beta Drugs Ltd. | BETA | 2,668.21 | 61.53 | 9.73 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,566.23 | 33.67 | 6.94 | 36.29 | 42.4 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,386.78 | 142.94 | 3.09 | 13.9 | 12.97 |
Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P/E ratio of 50.55x compared with the displayed peer median of 61.53x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 12.97%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 18,760.75 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Astrazeneca Pharma India Ltd.
This stock is attracting attention because the verified data combines a fresh price event with meaningful valuation and sector context. For investors scanning Market Movers and Stocks at 52 Week Low, the following points stand out.
- Fresh price trigger: Astrazeneca Pharma India Ltd. Share Price touched Rs 7,480, its new 52-week low, and remained near that level at Rs 7,498.90.
- Intraday weakness: The stock opened at Rs 7,580.50, which also marked the day’s high, before moving lower through the session.
- Large company size: Market capitalisation of Rs 18,760.75 crore is far above the Healthcare benchmark median and average in the supplied dataset.
- Mixed valuation profile: P/E of 50.55 is above the sector median of 21.42, while P/B of 1.94 is aligned with the sector median.
- Profitability lag: ROE of -0.78 and ROCE of 8.31 are below the Healthcare sector medians of 11.09 and 13.29 respectively.
- Peer contrast: Several supplied peers show stronger ROE and ROCE despite materially smaller market capitalisation.
About Astrazeneca Pharma India Ltd.
Astrazeneca Pharma India Ltd. is classified in the Healthcare sector in the supplied dataset. That places it within a market segment where investors typically evaluate companies through a mix of valuation, profitability and relative scale. In this case, Astrazeneca Pharma India Ltd. Share Price is being assessed against Healthcare benchmarks and peers rather than a narrower verified industry snapshot.
The market position implied by the data is notable. With a market capitalisation of Rs 18,760.75 crore, the company is substantially larger than the benchmark levels shown for the sector snapshot and larger than the listed peers supplied for comparison. That makes Astrazeneca Pharma India Ltd. Company News relevant not only for short-term Stock Updates but also for investors studying how a large Healthcare stock is performing relative to sector-wide valuation and return measures.
For readers using Univest for Astrazeneca Pharma India Ltd. Share Price Live tracking, the present focus is less about a headline percentage decline and more about the fact that the stock has moved to a fresh one-year low while trading on a P/E of 50.55, P/B of 1.94, ROE of -0.78 and ROCE of 8.31. Those metrics define the current market context.
Track Astrazeneca Pharma India Ltd. Share Price on Univest
Use Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors following Astrazeneca Pharma India Ltd. Share Price can use Univest to monitor live Share Price moves, 52-week high and 52-week low levels, valuation ratios, market capitalisation trends and sector comparisons in one place. Univest also helps users track Astrazeneca Pharma India Ltd. Stock News, Astrazeneca Pharma India Ltd. Share Price Today, peer positioning, and broader Healthcare market context without losing sight of the verified numbers driving the current story.
When a stock enters screens such as Top Losers Today, Bearish Stocks, Oversold Stocks or 52 Week Low Stocks, the most useful approach is to combine price action with Financial Analysis and Peer Comparison. That is where Univest adds context: it lets users follow Astrazeneca Pharma India Ltd. NSE and Astrazeneca Pharma India Ltd. BSE market data, compare valuation metrics like P/E Ratio and P/B Ratio, and keep the move in perspective as part of the Indian Stock Market and daily NSE News and BSE News flow.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest Astrazeneca Pharma India Ltd. Share Price Today?
Ans. Astrazeneca Pharma India Ltd. Share Price Today was Rs 7,498.90 at 9:53 AM IST on 21 August 2026. The stock was down Rs 5.40, or 0.07%, from the previous close of Rs 7,504.30.
Why is Astrazeneca Pharma India Ltd. Share Price in focus today?
Ans. The stock is in focus because it touched a fresh 52-week low of Rs 7,480 during the session. The verified data confirms the price event, while the supplied figures do not establish a company-specific catalyst for the move.
What was the fresh 52-week low for Astrazeneca Pharma India Ltd.?
Ans. Astrazeneca Pharma India Ltd. hit a fresh 52-week low of Rs 7,480 on 21 August 2026. The current price was Rs 7,498.90, which means the stock remained just Rs 18.90 above that new yearly low.
How did Astrazeneca Pharma India Ltd. trade intraday today?
Ans. The stock opened at Rs 7,580.50 and that also marked the day’s high. It later declined to Rs 7,480, the session low and fresh one-year low, before trading at Rs 7,498.90 during the update.
What does today’s trading volume show for Astrazeneca Pharma India Ltd.?
Ans. Current volume stood at 53 shares, while turnover was Rs 0.04 crore at the time of the update. That points to a fresh 52-week low event being recorded with limited absolute trading participation so far.
What is the market capitalisation of Astrazeneca Pharma India Ltd.?
Ans. Astrazeneca Pharma India Ltd. had a market capitalisation of Rs 18,760.75 crore. That is far above the Healthcare sector benchmark median of Rs 132.66 crore and average of Rs 467.25 crore in the supplied dataset.
How is Astrazeneca Pharma India Ltd. valued versus the Healthcare sector?
Ans. The stock trades at a P/E of 50.55 and P/B of 1.94. Compared with the Healthcare benchmark, its P/E is above the median 21.42 and average 48.98, while P/B matches the median 1.94.
What do the ROE and ROCE figures indicate for Astrazeneca Pharma India Ltd.?
Ans. ROE is -0.78 and ROCE is 8.31 for Astrazeneca Pharma India Ltd. Both are below the Healthcare sector medians of 11.09 and 13.29 respectively, indicating a weaker return profile than the benchmark.
How does Astrazeneca Pharma India Ltd. compare with selected peers?
Ans. Astrazeneca Pharma India Ltd. has a much larger market cap than the supplied peers, but its ROE and ROCE trail several of them. Its P/E of 50.55 is lower than some peers and higher than others.
What should investors monitor next in Astrazeneca Pharma India Ltd. Stock News?
Ans. Investors may watch whether Astrazeneca Pharma India Ltd. Share Price stays near the fresh 52-week low or moves away from it, while also tracking valuation, profitability metrics, sector benchmarks and peer positioning on Univest.
